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Introduction
The use of antiretroviral therapy produced a decrease in
morbidity and mortality rates in human immunodefi-
ciency virus type 1 (HIV-1)-infected children.
Objectives
To update a previous epidemiological survey that demon-
strated the benefits of HAART on the clinical outcome of
HIV-1 vertically infected children.
Materials and methods
We carried out a retrospective observational survey involv-
ing 346 HIV-1 vertically infected children (≤17 years old)
living in the Autonomic Community of Madrid. The anal-
ysis was stratified in 5 calendar periods (CP) on the basis
of the changing antiretroviral treatment protocols: CP1
(80-89): not treatment was used in this period; CP2 (90-
93): the standard of care was monotherapy with nucleo-
side analogue reverse-transcriptase inhibitor (NRTI); CP3
(94-96): when dual-NRTI therapy was administered; CP4
(97-98): the antiretroviral regiments was HAART with a
combinations of three or more drugs; CP5 (99-06): when
> 60% of children were on HAART and less than 10%
were untreated. We assumed that vertical transmission
occurred on the birth day. We calculated the mean CD4+
T cells count and log10 viral load per year, and we studied
their trend over time. Then, we estimated the Kaplan-
Meier curve to analyze the occurrence of AIDS and death.
Finally, we performed a Cox regression analysis to calcu-
late the relative risk (RR) for absence of AIDS and survival.
Results
We observed an increase of the mean CD4+ T-cell percent-
age and a concomitant decrease of the plasma log10 viral
load since 1997. A total of 205 kids had a diagnosis of
AIDS (59.2%) and 122 died (35.3%). The last two periods
(CP4 and CP5) had significantly fewer AIDS cases com-
pared to the previous (P<0.001); in particular, the relative
risk of the CP5 compared to the CP1 was of 5.5 (95%CI:
3.60-8.51). In the CP5 there were less death cases com-
pared with the other periods (P<0.01) and the RR was of
9.7 (95%CI: 3.49-27.2) compared to the CP1, when the
event of death occurred in more than the 20% of the chil-
dren.
Conclusions
We confirmed the benefits of HAART in reducing adverse
clinical outcomes as AIDS and death in HIV-1 vertically
infected children in our cohort of kids living in the Auto-
nomic Community of Madrid.
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